wild type EGFR and ALK Non squamous with EGFR mutation EGFR Non squamous with

Wild type egfr and alk non squamous with egfr

This preview shows page 24 - 30 out of 30 pages.

wild-type EGFR and ALK Non-squamous with EGFR mutation (EGFR + ) Non-squamous with ALK-EML4 rearrangement (ALK + )
Image of page 24
Non-Small Cell Lung Cancer Treatment Resectable (Stages I, II, III) Surgery is the treatment of choice Radiation In medically inoperable can be used with curative intent
Image of page 25
Non-Small Cell Lung Cancer Treatment Squamous histology Gemcitabine + cisplatin Most common adjuvant regimen Cisplatin + etoposide Gems are square shape
Image of page 26
Non-Small Cell Lung Cancer Treatment Non-squamous with wild-type EGFR and ALK First line Carboplatin + paclitaxel + bevacizumab Carboplatin + pemetrexed Second-line Docetaxel + ramucirumab Nivolumab Pembrolizumab
Image of page 27
Non-Small Cell Lung Cancer Treatment - Genomics EGFR + Mutations Erlo tinib A fat inib Ge fit inib ALK + Rearrangements Crizotinib Ceritinib
Image of page 28
Non-Small Lung Cancer Maintenance Therapy Maintenance therapy One of the agents form primary regimen therapy or some other single agents Patients with NCSLC non-squamous histology if responded to 4-6 cycles of chemotherapy Continue maintenance
Image of page 29
Questions?
Image of page 30

You've reached the end of your free preview.

Want to read all 30 pages?

  • Spring '17
  • Non-small Cell Lung Cancer, Cell Lung Cancer Treatment

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture